Related Experiment Videos

[Plurality in the determinism of organophosphorus teratogenic effects (author's transl)]

Experientia
|January 1, 1976
PubMed

Insights

Nicotinamide (NA) partially protected quail embryos from bidrin-induced limb and beak defects. Pralidoxime (2-PAM) effectively countered vertebral abnormalities from bidrin and parathion, indicating diverse mechanisms in organophosphate-induced teratogenicity.

Area of Science:

  • Developmental toxicology
  • Embryology
  • Neuroscience

Background:

  • Organophosphorus compounds (OPCs) are widely used pesticides with known neurotoxic effects.
  • OPCs can induce developmental abnormalities (teratogenicity) in embryos.
  • The specific mechanisms underlying OPC-induced teratogenicity are not fully understood.

Purpose of the Study:

  • To investigate the efficacy of nicotinamide (NA) and pralidoxime (2-PAM) in preventing specific organophosphate-induced teratogenic effects in quail embryos.
  • To explore the potential for distinct etiological pathways in organophosphate-induced developmental defects.

Main Methods:

  • Quail embryos were exposed to organophosphates (bidrin, parathion) during development.
  • Embryos were treated with nicotinamide or pralidoxime to assess protective effects.
  • Teratogenic effects, including beak, leg, and vertebral abnormalities, were evaluated.

Main Results:

  • Nicotinamide effectively prevented beak and leg abnormalities induced by bidrin.
  • Nicotinamide showed limited efficacy against vertebral defects caused by bidrin and parathion.
  • Pralidoxime significantly alleviated or abolished vertebral deficiencies induced by both bidrin and parathion.

Conclusions:

  • The findings suggest a plurality in the determinism of teratogenic effects induced by organophosphorus compounds.
  • Different OPC-induced developmental abnormalities may arise from distinct underlying mechanisms.
  • The differential efficacy of NA and 2-PAM highlights the complexity of OPC teratogenesis.

Related Concept Videos